Al Dawaa Medical Services Co. (ALDAWAA) intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Consumer Staples Distribution & Retail. Listed on Saudi Exchange Tadawul.
Al Dawaa Medical Services Company operates pharmacy retail chains in Saudi Arabia and Bahrain, selling medicines, cosmetics, and beauty products. It also engages in pharmaceutical wholesale and warehousing, and manufactures single-use medical products and equipment such as examination tables and thermometers. The company was founded in 1993 and is based in Al Khobar.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 109.49 compared to a market price of SAR 38.76 (Trading significantly below DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 17% over the three-year period, while net income remained roughly flat, declining slightly by about 2%, indicating profitability did not keep pace with sales growth. Operating cash flow declined further, by about 9%, moving in the opposite direction of revenue. Overall, the company's historical financial performance shows revenue growth alongside broadly stable net income and a modest decline in operating cash flow.
Over the 5 years on record, dividend per share moved both up and down, from SAR 1.25 to a recent SAR 1.89, with a low of SAR 1.25 and a high of SAR 2.52 along the way. Payments have been made on a Quarterly basis throughout this period. The company's dividend history shows no consistent year-over-year direction. Current dividend yield is approximately 6.50%, with a payout ratio of approximately 66.57%.
TASIV's Competitive Advantage assessment for this company is High (70/100), based on profitability, predictability, financial strength, and growth resilience.
This company currently meets the following TASIV screener criteria: Dividend Stock Screener.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of Al Dawaa Medical Services Co. (ALDAWAA) is approximately SAR 109.49, compared to a current market price of SAR 38.76. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Al Dawaa Medical Services Co. (ALDAWAA) is currently "Trading significantly below DCF model value".
Al Dawaa Medical Services Co. (ALDAWAA)'s dividend yield is approximately 6.50%, with a payout ratio of approximately 66.57%, based on TASIV's most recent verified data.
Loading 4163...